A library of 192 structurally diverse 1,4-
Rigorous analytical verification of the chemical integrity and yield of a representative collection of the diverse derivatives was carried out. In addition, the library of derivatives was evaluated for binding to the cholecystokinin A receptor by employing a competitive radioligand binding assay. This provided detailed structure versus activity relationships that were confirmed by independent large-scale synthesis and evaluation of several of the 1,4-benzodiazepine derivatives.
An essential early step in the development of therapeutic agents continues to be the identification of lead compounds that interact with the receptor or enzyme target of interest. Many analogs of the lead compounds are then constructed to define the key recognition elements for maximal activity. In almost all cases, the initial lead compounds are identified by the target-based screening of large collections of compounds and/or biological extracts. Unfortunately, despite recent technological advances that have greatly expedited screening procedures to allow hundreds of thousands to millions of compounds to be efficiently evaluated (1) , target-based screening often does not result in the identification of suitable lead compounds due to the limited size and inadequate structural diversity of the collections of compounds that are being evaluated.
Very powerful chemical and biological methods have recently been developed for the generation of large combinatorial libraries of peptides and oligonucleotides that are then screened against a specific receptor or enzyme to determine the important structural features of the biopolymer for binding to that receptor or enzyme (2, 3) . By employing these methods, numerous peptide and oligonucleotide ligands have been identified to diverse receptor targets, clearly demonstrating the power of combinatorial synthesis and screening strategies. Unfortunately, peptides and oligonucleotides generally have very poor oral activities, rapid in vivo clearing times, and thus have limited utility as bioavailable therapeutic agents. The combinatorial synthesis and screening of bioavailable organic compounds would be a powerful extension of this approach. Toward this goal, the combinatorial synthesis and evaluation of nonbiological oligoamides (4) and oligocarbamates (5) (8) , opioid receptor ligands (9), platelet-activating factor antagonists (10), human immunodeficiency virus trans-activator Tat antagonists (11) , GPIIbIIIa inhibitors (12) , reverse transcriptase inhibitors (13) , and ras farnesyltransferase inhibitors (14 Combinatorial Benzodiazepine Synthesis. Hydroxy-functionalized 2-aminobenzophenone derivatives la and lb were coupled to the 4-hydroxymethylphenoxyacetic acidcleavable linker by deprotonation with 1 equivalent of potassium bis(trimethylsilyl)amide followed by alkylation with allyl 4-bromomethylphenoxyacetate ( Fig. 1) and 0.055 M in hydroxybenzotriazole and diisopropylcarbodiimide. The derivatized pins were then rinsed with DMF (twice), MeOH (air-dried), CH2Cl2 (twice), and DMF followed by treatment with 20%/6 piperidine in DMF (once for 1 min and then once for 20 min) to provide 4 (Fig. 2 ). The resulting pins were then rinsed with DMF (three times), MeOH (air-dried), and CH2Cl2 (twice) and then immersed in a 0.2 M solution of the appropriate Fmoc-protected amino acid fluoride in CH2CI2 to provide anilide 5 . To obtain high yields in the coupling step, the Fmoc-amino acid fluorides should be prepared employing cyanuric fluoride (15) , and the workup should include extraction with dilute aqueous bicarbonate (three times) and 1 M aqueous sodium bisulfate (three times) to remove any cyanuric fluoride byproducts (further purification is not necessary). The coupling reaction was allowed to continue for 3 days to ensure complete coupling of the most hindered amino acid derivatives, for example, valine or isoleucine. To prevent evaporation of the solvent, the pins immersed in the wells of the Beckman microtiter plate were maintained in a CH2Cl2-saturated atmosphere by placing the plate in a dessicator containing a layer of CH2Cl2. The pins were then rinsed with CH2Cl2 (three times), MeOH (airdried), and DMF (twice), followed by treatment with 20% piperidine in DMF (once for 1 min and then once for 20 min) to remove the Fmoc protecting group. After rinsing with DMF, MeOH (air-dried), and again DMF (twice), the pins were immersed in 5% (vol/vol) acetic acid in butanol or DMF at 60-80TC for 12 h to provide the cyclic product 6. The pins were then rinsed with DMF (three times) and tetrahydrofuran (THF) (twice). The pins and all necessary reagents were transferred to a glove bag preflushed with N2 (g). After a final THF rinse, the pins were immersed in 0.12 M lithiated 4-phenylmethyl-2-oxazolidinone in THF containing 10%6 DMF at 0C for 30 min. The pins were then immersed, without rinsing, in a 0.40 M solution of the alkylating agent in DMF that had been prepared immediately before alkylation. After 1 h at 0C, the alkylation sequence was repeated and then allowed to warm to room temperature over several hours. The pins were removed from the glove bag, rinsed with DMF, DMF/H20, MeOH (air-dried), and CH2Cl2, and cleaved from the support by immersion in 85:10:5 (vol/vol) trifluoroacetic acid/dimethyl sulfide/H20 for 24 h. For benzodiazepine derivatives incorporating tryptophan, 85:5:5:5 (vol/vol) trifluoroacetic acid/dimethyl sulfide/H20/1,2-ethanedithiol was employed as the cleavage mixture to prevent oxidative decomposition of the indole ring (16). The cleavage mixture was then removed with a Jouan RC10.10 concentrator equipped with a microtiter-plate rotor so that the free 1,4-benzodiazepine derivatives were spatially separated in the individual wells of the microtiter plate.
Analytical Evaluation of the 1,4-Beno pl Library. Out of the library of 192 benzodiazepine derivatives, 28 unique derivatives were evaluated by reverse-phase HPLC analysis using a Rainin C18 column, a 15-100% gradient of methanol in water buffered with 0.1% trifluoroacetic acid, and UV detection at 350 nm. The compound corresponding to the major peak was isolated and subjected to fast atom bombardment mass spectrometric analysis to verify the structure of the benzodiazepine derivative. Sixteen of the compounds were derived from aminobenzophenones la or lb, valine, and each of the eight alkylating agents employed in the library, and 12 of the compounds were derived from aminobenzophenone la, each of the 12 amino acids that were employed in the library, and ethyl iodide.
In addition, for the eight benzodiazepine derivatives constructed from 2-aminobenzophenone la, valine, and each of the eight alkylating agents and for the 12 benzodiazepine derivatives constructed from 2-aminobenzophenone la, each of the 12 amino acids, and ethyl iodide, 200 A4 of a stock solution of fluorenone (4 mg/ml) in DMF was added, followed by reverse-phase HPLC analysis to determine the relative peak area of the 1,4-benzodiazepine derivative to the fluorenone standard as monitored at 350 nm. The quantity of material produced per pin was then calculated from the extinction coefficients of the derivatives that were determined on material prepared on large scale (data not shown).
Racemization of the amino acid stereocenter during the synthesis sequence was also evaluated for 1,4-benzodiazepines, prepared from 2-aminobenzophenone la, both D-and L-alanine, and ethyl iodide, by etherification of the 1,4-benzodiazepine derivatives with excess diazomethane in 1:1 (vol/vol) ethyl acetate/MeOH for 12 h. No racemization (<2%) was detected by HPLC analysis on a 10 mm x 25 cm covalent D-dinitrobenzoylphenylglycine chiral pirkle column from Regis (Morton Grove, IL), with 4% (vol/vol) isopropanol in hexane as the eluent, a flow rate of 6 ml/min, and absorbance monitored at 260 nm (17) . The (23, 24) . The capability to determine the yield and chemical integrity of the structurally diverse derivatives is, therefore, an essential requirement. In addition, by maintaining compounds in a spatially separate fashion, biological evaluation provides detailed structure versus activity relationships that cannot readily be obtained employing pools of compounds. (iv) The final criteria in choosing a strategy for the construction of a library of organic compounds was to employ a strategy that did not require the development of costly instrumentation and, rather, to rely on instrumentation that had already been developed for preexisting highthroughput screening procedures.
According to these criteria we have chosen to construct the 1,4-benzodiazepine derivatives from three readily available components, 2-aminobenzophenones, amino acids, and alkylating agents, providing access to a large number of structurally diverse derivatives (vida infra) (6) . In constructing the library, we have also chosen to employ Geysen's pin apparatus developed for peptide epitope mapping (25 For 20 unique derivatives, where again each of the 2-aminobenzophenones, amino acids, and alkylating agents were incorporated into at least one of the derivatives, a set volume of a stock solution containing fluorenone as an internal standard was added followed by HPLC analysis. The quantity of material produced per pin then was determined directly by correlating the peak area of the benzodiazepine derivative relative to the internal standard with the relative extinction coefficients of the different 1,4-benzodiazepine derivatives. Per pin, the average amount of 1,4-benzodiazepine produced was 86 nmol (theoretical yield is 100 nmol). The 1,4-benzodiazepine prepared from aminobenzophenone la, isoleucine, and ethyl iodide provided the least amount of material (67 nmol). Finally, no racemization of the benzodiazepine derivatives prepared from 2-aminobenzophenone la, L-and D-alanine, and ethyl iodide was observed as determined by chiral HPLC analysis.
Biological Evaluation of the 1,4-Benzodlazepine Library. In addition to rigorously demonstrating the chemical integrity of the library, we also wanted to demonstrate that the library could be evaluated reliably to obtain detailed structure versus activity relationships against important receptor and enzyme targets. As the initial target, we chose to assay the library for ligands to the CCK A receptor for several reasons. (i) The CCK A receptor has wide-ranging biological functions with potential therapeutic applications (26) . (ii) Researchers at Merck have identified a number of 1,4-benzodiazepine derivatives that bind to this receptor (27) . (iii) The competitive radioligand binding assay for this receptor target is amenable to high throughput. The results of the simultaneous evaluation of all 192 benzodiazepines in the library employing the competitive radioligand binding assay in a microtiter format with the ligands at 30 ,uM are shown in Fig. 3 . In the preliminary screen shown, clearly the benzodiazepine derivatives that incorporated either D-or L-tryptophan bound much more tightly than the benzodiazepine derivatives that incorporated other amino acids. A second evaluation was then performed on the 32 benzodiazepines that incorporated D-or L-tryptophan at 7.5 juM, 3 .0 ,uM, 1.0 ,uM, 0.3 ,uM, 0.1 pM, and 0.03 ,uM (data not shown). The data from these experiments clearly demonstrated two additional levels of structural discrimination, wherein benzodiazepines incorporating 2-aminobenzophenone lb showed significantly higher affinity than benzodiazepines incorporating 2-aminobenzophenone la, and benzodiazepines incorporating D-tryptophan showed higher affinity than benzodiazepines incorporating L-tryptophan. Finally, in accord with Merck's data, introduction of different alkyl groups Rc had a more modest effect on binding affinity.
To confirm the assay results obtained by evaluation of the library, a selected number of benzodiazepine derivatives from the library were synthesized on a large scale and purified, and the IC"0 values were determined exactly by performing the assays in triplicate relative to a known inhibitor, compound 9, developed by researchers at Merck (27) ( Table 1 Receptor binding affinity of the 1,4-benzodiazepine derivatives at 7.5 AM is monitored by the percent displacement of 17-I-labeled CCK-8 from the CCK A receptors as observed by the relative signal intensity upon Phosphorlmager exposure. Group Rc corresponds to the side chain of the amino acid that is incorporated into the benzodiazepine structure. The absolute configuration for most compounds is S, except for the derivatives in the last three columns (incorporating amino acids A, F, and W), where the absolute configuration is R. Nle, norleucine; Bn, benzyl; n-Pr, n-propyl. In the receptor binding assay, the two benzodiazepine derivatives prepared from valine with Rc = H were replaced with compound 9 (Table 1) .
indoles has been constructed in a combinatorial fashion from three components, 2-aminobenzophenones, amino acids, and alkylating agents, by employing Geysen's pin apparatus. Rigorous analytical verification of the chemical integrity and yield of a representative collection of the diverse derivatives has also been accomplished. In addition, the library of derivatives was evaluated for binding to the CCK receptor by employing a simultaneous competitive radioligand binding assay. This provided detailed structure versus activity relationships that were confirmed by independent large-scale synthesis and evaluation of several of the derivatives.
By employing the described protocols and reaction conditions, a greatly expanded library could rapidly be accessed by including the >40 commercially available preprotected natural and unnatural amino acids that are compatible with our solid-phase synthesis protocols.t In addition, >50 alkylating agents are available commercially, many of which have already been evaluated with our solid-phase synthesis strategy, including cinnamyl bromide derivatives, iodoacetonitrile, and a range of iodoalkanes, alkenes, and alkynes. Furthermore, we have developed (unpublished data) a method to rapidly and efficiently construct on solid-support numerous structurally diverse 2-aminobenzophenone derivatives incorporating a variety ofchemical functionalities from commercially available precursor molecules. Geysen has reported (25) that 2000 unique hexapeptide derivatives could be constructed in <2 weeks by employing his pin apparatus. Considering that more than twice as many chemical steps are required to synthesize a hexapeptide than are necessary to synthesize a 1,4-benzodiazepine according to our synthesis strategy, the construction of >10,000 benzodiazepine derivatives should certainly be feasible.
The results reported in this article indicate that the combinatorial synthesis of nonpolymeric organic molecules involving multistep reaction sequences and incorporating a variety of sensitive chemical functionalities will provide effective and reliable access to compound libraries for the identification of lead structures and for the rapid determination of structure versus activity relationships. The principles and methods outlined in this article should be applicable to a number of other therapeutically important classes of organic compounds and designed recognition elements. tFor uniformly high yields in the synthesis of benzodiazepine de- rivatives incorporating amino acids with side-chain functionality, for example, Asp, Glu, Lys, Tyr, Asn, Gln, Met, Ser, and Trp, 2,6-di-t-butylpyridine should be included in the acid fluoride coupling step (6) .
